Marshall Wace North America’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $99.9M | Buy |
1,663,270
+151,308
| +10% | +$9.09M | 0.43% | 46 |
|
|
2021
Q2 | $90.6M | Sell |
1,511,962
-230,647
| -13% | -$13.8M | 0.38% | 54 |
|
|
2021
Q1 | $86.6M | Buy |
1,742,609
+1,276,858
| +274% | +$63.5M | 0.36% | 59 |
|
|
2020
Q4 | $23.3M | Buy |
+465,751
| New | +$23.3M | 0.1% | 218 |
|
|
2020
Q3 | – | Sell |
-288,113
| Closed | -$15.2M | – | 1204 |
|
|
2020
Q2 | $15.2M | Buy |
288,113
+171,435
| +147% | +$9.07M | 0.1% | 212 |
|
|
2020
Q1 | $5.21M | Sell |
116,678
-2,024,687
| -95% | -$90.4M | 0.04% | 314 |
|
|
2019
Q4 | $107M | Sell |
2,141,365
-1,270,311
| -37% | -$63.3M | 0.52% | 50 |
|
|
2019
Q3 | $152M | Buy |
3,411,676
+398,027
| +13% | +$17.7M | 0.86% | 27 |
|
|
2019
Q2 | $124M | Buy |
3,013,649
+2,898,998
| +2,529% | +$120M | 0.77% | 31 |
|
|
2019
Q1 | $4.64M | Buy |
+114,651
| New | +$4.64M | 0.03% | 337 |
|
|
2018
Q3 | – | Sell |
-85,404
| Closed | -$3M | – | 927 |
|
|
2018
Q2 | $3M | Buy |
+85,404
| New | +$3M | 0.02% | 653 |
|
|
2017
Q4 | – | Sell |
-35,976
| Closed | -$1.22M | – | 1368 |
|
|
2017
Q3 | $1.22M | Sell |
35,976
-287,752
| -89% | -$9.78M | 0.01% | 907 |
|
|
2017
Q2 | $11M | Buy |
+323,728
| New | +$11M | 0.08% | 297 |
|
|
2013
Q4 | – | Sell |
-12,694
| Closed | -$330K | – | 696 |
|
|
2013
Q3 | $330K | Sell |
12,694
-154,862
| -92% | -$4.03M | 0.01% | 502 |
|
|
2013
Q2 | $3.96M | Buy |
+167,556
| New | +$3.96M | 0.31% | 111 |
|